Results 1 to 10 of about 727 (68)

Purification of the human complement control protein C3b inactivator [PDF]

Biochemical Journal, 1980
An alternative method of isolation from human plasma is described for C3b inactivator, C3bINA, the proteinase that in conjunction with either beta 1H or C4b-binding protein will hydrolyse respectively C3b or C4b, the activation products of the third, C3 and fourth, C4, components of complement. The purification is by chromatography of plasma on columns
L G, Crossley, R R, Porter
openaire   +2 more sources

Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution. [PDF]

The Journal of experimental medicine, 1977
The complement regulatory enzyme, C3b inactivator (C3bINA), has been purified from human serum by affinity chromatography on an anti-C3bINA Sepharose column. Subsequent chromatography on DEAE-cellulose and removal of IgG with anti-IgG Sepharose resulted in a product which was found to be homogeneous by polyacrylamide gel electrophoresis at pH 8.9 and ...
M K, Pangburn, R D, Schreiber, H J, Müller-Eberhard   +2 more
openaire   +2 more sources

Diversity of Sites for Measles Virus Binding and for Inactivation of Complement C3b and C4b on Membrane Cofactor Protein CD46 [PDF]

Journal of Biological Chemistry, 1995
The complement system membrane cofactor protein (MCP) CD46 serves as a C3b/C4b inactivating factor for the protection of host cells from autologous complement attack and as a receptor for measles virus (MV). MCP consists of four short consensus repeats (SCR) which are the predominant extracellular structural motif.
K, Iwata, T, Seya, Y, Yanagi, J M, Pesando, P M, Johnson, M, Okabe, S, Ueda, H, Ariga, S, Nagasawa   +8 more
openaire   +2 more sources

Downregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis

International Brazilian Journal of Urology, 2012
Purpose To investigate the use of ClinProt technique to identify cancer markers in plasma of patients suffering from squamous cell carcinoma of the penis (SCCP). Materials and Methods Plasma of 36 healthy subjects and 25 patients with
Paulo Ornellas, Antonio Augusto Ornellas, Clizia Chinello, Erica Gianazza, Veronica Mainini, Marta Cazzaniga, Denise Abreu Pereira, Vanessa Sandim, Ana Sheila Cypriano, Leandro Koifman, Paulo Cesar Barbosa da Silva, Gilda Alves, Fulvio Magni   +12 more
doaj   +1 more source

Genetic variant in complement receptor 1 (CR1, CD35) is associated with a cluster of severe fatal COVID-19 in a family. [PDF]

J Infect, 2023
Danial-Farran N, Khlaila M, Avraham-Kelbert M, Chazan B, Khayat M, Winder A, Shalev S, Bisharat N.   +7 more
europepmc   +1 more source

Subversion of the Complement System by Pseudomonas aeruginosa. [PDF]

J Bacteriol, 2023
Hastings CJ, Syed SS, Marques CNH.
europepmc   +1 more source

Pseudomonas aeruginosa and the Complement System: A Review of the Evasion Strategies. [PDF]

Microorganisms, 2023
González-Alsina A, Mateu-Borrás M, Doménech-Sánchez A, Albertí S.   +3 more
europepmc   +1 more source

Atypical haemolytic uremic syndrome with refractory multiorgan involvement and heterozygous CFHR1/CFHR3 gene deletion. [PDF]

BMC Nephrol, 2023
Diep J, Potter D, Mai J, Hsu D.
europepmc   +1 more source

CFH-CFHR1 hybrid genes in two cases of atypical hemolytic uremic syndrome. [PDF]

J Hum Genet, 2023
Sugawara Y, Kato H, Nagasaki M, Yoshida Y, Fujisawa M, Minegishi N, Yamamoto M, Nangaku M.   +7 more
europepmc   +1 more source

Anti-factor H antibody and its role in atypical hemolytic uremic syndrome. [PDF]

Front Immunol, 2022
Raina R, Mangat G, Hong G, Shah R, Nair N, Abboud B, Bagga S, Sethi SK.   +7 more
europepmc   +1 more source